Clinical Study of the Safety and Efficacy of BCMA CAR-NK
Clinical trial NCT05652530 · UNKNOWN
Trial details
- NCT number
- NCT05652530
- Sponsor
- Shenzhen Pregene Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-13
- Primary completion
- 2023-09-30
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.